2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue European Journal of Medicinal Chemistry Année : 2023

2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling

Fichier non déposé

Dates et versions

hal-04552603 , version 1 (19-04-2024)

Identifiants

Citer

Moataz Shaldam, Denisa Hendrychová, Radwan El-Haggar, Veronika Vojáčková, Taghreed Majrashi, et al.. 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry, 2023, 258, pp.115610. ⟨10.1016/j.ejmech.2023.115610⟩. ⟨hal-04552603⟩
6 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More